Immunotherapy-induced eczema treated with dupilumab

J Eur Acad Dermatol Venereol. 2024 May;38(5):e447-e449. doi: 10.1111/jdv.19707. Epub 2023 Dec 12.

Authors

Angelo Massimiliano D'Erme¹, Cristian Fidanzi², Nicolò Mori², Gianna Musettini³, Samanta Cupini⁴, Cecilia Barbara⁴, Giacomo Allegrini⁴, Giovanni Bagnoni¹, Agata Janowska²

Affiliations

¹ Melanoma and Skin Cancer Unit AVNO (Area Vasta Nord Ovest) and Unit of Dermatology, Livorno Hospital, Livorno, Italy.
² Unit of Dermatology, University of Pisa, Pisa, Italy.
³ Unit of Pathology, Livorno Hospital, Livorno, Italy.
⁴ Unit of Oncology, Livorno Hospital, Livorno, Italy.

PMID: 38084780
DOI: 10.1111/jdv.19707

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized* / adverse effects
Antibodies, Monoclonal, Humanized* / therapeutic use
Eczema* / chemically induced
Eczema* / drug therapy
Female
Humans
Immunotherapy / adverse effects
Male

Substances

Antibodies, Monoclonal, Humanized
dupilumab